# A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224

> **NCT04932512** · PHASE2 · COMPLETED · sponsor: **Ionis Pharmaceuticals, Inc.** · enrollment: 160 (actual)

## Conditions studied

- Steatohepatitis, Nonalcoholic

## Interventions

- **DRUG:** ION224
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04932512
- **Lead sponsor:** Ionis Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-17
- **Primary completion:** 2024-01-10
- **Final completion:** 2024-02-28
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04932512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04932512, "A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04932512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*